Corcept Therapeutics | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Alaunos Therapeutics USD 4K 822K 2024-10
ANI Pharmaceuticals USD 236.83M 35.02M 2025-06
Ardelyx USD 77.83M 7.33M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
J&J USD 56.9B 6.58B 2025-03
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Merck USD 26.04B 863M 2025-06
Novartis USD 31.71B 95M 2025-06
Novartis USD 28.69B 560M 2024-12
Pacira USD 313.16M 1.57M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
TG Therapeutics USD 171.89M 11.68M 2025-06


Corcept Therapeutics Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.